Association of the metabolic syndrome with intracranial atherosclerotic stroke

Oh Young Bang, J. W. Kim, J. H. Lee, M. A. Lee, philhyu Lee, I. S. Joo, K. Huh

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.

Original languageEnglish
Pages (from-to)296-298
Number of pages3
JournalNeurology
Volume65
Issue number2
DOIs
Publication statusPublished - 2005 Jul 26

Fingerprint

Intracranial Arteriosclerosis
Stroke
Regression Analysis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Bang, O. Y., Kim, J. W., Lee, J. H., Lee, M. A., Lee, P., Joo, I. S., & Huh, K. (2005). Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology, 65(2), 296-298. https://doi.org/10.1212/01.wnl.0000168862.09764.9f
Bang, Oh Young ; Kim, J. W. ; Lee, J. H. ; Lee, M. A. ; Lee, philhyu ; Joo, I. S. ; Huh, K. / Association of the metabolic syndrome with intracranial atherosclerotic stroke. In: Neurology. 2005 ; Vol. 65, No. 2. pp. 296-298.
@article{2b890807d4594cccabf6d9e9bf02d718,
title = "Association of the metabolic syndrome with intracranial atherosclerotic stroke",
abstract = "To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.",
author = "Bang, {Oh Young} and Kim, {J. W.} and Lee, {J. H.} and Lee, {M. A.} and philhyu Lee and Joo, {I. S.} and K. Huh",
year = "2005",
month = "7",
day = "26",
doi = "10.1212/01.wnl.0000168862.09764.9f",
language = "English",
volume = "65",
pages = "296--298",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Association of the metabolic syndrome with intracranial atherosclerotic stroke. / Bang, Oh Young; Kim, J. W.; Lee, J. H.; Lee, M. A.; Lee, philhyu; Joo, I. S.; Huh, K.

In: Neurology, Vol. 65, No. 2, 26.07.2005, p. 296-298.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association of the metabolic syndrome with intracranial atherosclerotic stroke

AU - Bang, Oh Young

AU - Kim, J. W.

AU - Lee, J. H.

AU - Lee, M. A.

AU - Lee, philhyu

AU - Joo, I. S.

AU - Huh, K.

PY - 2005/7/26

Y1 - 2005/7/26

N2 - To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.

AB - To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=22544450816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22544450816&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000168862.09764.9f

DO - 10.1212/01.wnl.0000168862.09764.9f

M3 - Article

C2 - 16043803

AN - SCOPUS:22544450816

VL - 65

SP - 296

EP - 298

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 2

ER -